Parasitic worms, or soil-transmitted helminths (STH), are among the most prevalent causes of illness among the world’s poorest and most vulnerable populations, especially children. Close to a quarter of the world’s population is infected with at least one species of STH, and globally an estimated 870 million children are at risk of a new infection
Regular mass deworming of children once or twice a year has greatly contributed to the reductionin the prevalence of worms in several countries. National, school-based deworming programs are the most efficient and cost-effective way to reach kids, and are a cornerstone of addressing the public health threat of STH and schistosomiasis in a growing number of countries.
But there is a growing recognition that treatment of children alone might not be sufficient to break the transmission of worm infections. Infected adults constitute a latent reservoir of worm eggs and present a significant re-infection risk to children, in particular for hookworm, one of the three STH. So, how do we reduce the reinfection of children by treating adults? Enter Take Up, a new research project of Evidence Action's Deworm the World Initiative.
We are very proud and grateful for the recent grant of $10.8 million to our Deworm the World Initiative from Good Ventures.
Good Ventures supported GiveWell’s “top charities” for the 2015 giving season, and we are honored to be part of this exemplary group of organizations.